戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 521作成日:2026年10月23日

tert-Butyl piperazine-1-carboxylate → N-(4-methoxy-3-piperazin-1-yl-phenyl)-acetamide

https://huagongshe.com/ja/reaction/521

反応式

関与物質

役割名称HCID仕込み量
反応物tert-Butyl piperazine-1-carboxylateHCID 143452—
反応物N-(3-bromo-4-methoxyphenyl)acetamideHCID 244158—
試薬Sodium t-butoxideHCID 23676156—
触媒Palladium (II) acetateHCID 4144353—
触媒2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenylHCID 16217985—
溶媒TolueneHCID 1140—
生成物N-(4-methoxy-3-piperazin-1-yl-phenyl)-acetamideHCID 8248061450.91%

反応条件

温度100 °C

反応手順

A solution of N-(3-bromo-4-methoxyphenyl)acetamide (0.5 g, 2.05 mmol) dissolved in toluene (5 mL) was treated with tert-butyl piperazine-1-carboxylate (0.382 g, 2.05 mmol), diacetoxypalladium (0.046 g, 0.20 mmol), dicyclohexyl(2',6'-diisopropoxybiphenyl-2-yl)phosphine (0.191 g, 0.41 mmol) and sodium 2-methylpropan-2-olate (0.433 g, 4.51 mmol) in a sealed tube. The resulting mixture was degassed and stirred at 100 °C for 8 hours in a microwave. The mixture was pre-absorbed onto silica. The crude product was purified by flash silica chromatography, elution 50% ethyl acetate in Heptane. Pure fractions were evaporated to dryness to afford intermediate. The intermediate was dissolved in 4M HCl in dioxane (10mL) and stirred at RT overnight. The mixture was evaporated to give N-(4-methoxy-3-(piperazin-1-yl)phenyl)acetamide (0.260 g, 50.9 %) as a tan solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-d3fce1c8e3204b57a80e5c0d53c5c1f7
出典メモ750 AstraZeneca ELN dataset